Tag: approves

Posted on

FDA Approves Teva’s Cinqair for the Treatment of Severe Asthma – Pharmaceutical Technology Magazine (press release) (blog)


Lung Disease News

FDA Approves Teva's Cinqair for the Treatment of Severe Asthma
Pharmaceutical Technology Magazine (press release) (blog)
FDA approved Teva Pharmaceutical's Cinqair (reslizumab) on March 23, 2016 for use with other asthma medicines for the maintenance treatment of severe asthma in patients 18 years and older. Cinqair is approved for patients who have a history of severe …
FDA Approves Teva's Asthma Drug Cinqair as Add-on TreatmentLung Disease News
Nucala and Cinqair for the Treatment of Severe AsthmaAbout – News & Issues

all 3 news articles »

View full post on asthma – Google News

Posted on

FDA Approves Cinqair To Treat Severe Asthma – Pharmacy Practice News


Medscape

FDA Approves Cinqair To Treat Severe Asthma
Pharmacy Practice News
The FDA has approved reslizumab (Cinqair, Teva Pharmaceuticals) as an add-on maintenance treatment for patients aged 18 years and older with an eosinophilic phenotype asthma, who have a history of severe exacerbations despite receiving their current …
FDA approves reslizumab to treat severe asthmaPharmacy Today, American Pharmacists Association, pharmacist.com
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
Cinqair Receives FDA Approval As Treatment For Severe AsthmaTech Times
Healio –Globes
all 61 news articles »

View full post on asthma – Google News

Posted on

FDA approves reslizumab to treat severe asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com


Medscape

FDA approves reslizumab to treat severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
FDA has cleared reslizumab (Cinqair—Teva) for use with other asthma medicines for the maintenance treatment of severe asthma in adults. The drug is indicated for patients with a history of severe asthma attacks despite using their current asthma …
FDA approves Cinqair to treat severe asthmaFDA.gov
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
FDA Approves Teva's Asthma Injection to Treat Severe AsthmaNews Every day
Globes –UPI.com
all 55 news articles »

View full post on asthma – Google News

Posted on

FDA approves Cinqair to treat severe asthma – FDA.gov


Medscape

FDA approves Cinqair to treat severe asthma
FDA.gov
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of …
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
FDA Approves Reslizumab for Adults With Severe AsthmaMedPage Today
FDA clears Teva's asthma med CinqairSeeking Alpha
Monthly Prescribing Reference (registration)
all 25 news articles »

View full post on asthma – Google News

Posted on

US FDA Approves GSK Asthma Drug – ObserverLeader.com (blog)


Ledger Gazette

US FDA Approves GSK Asthma Drug
ObserverLeader.com (blog)
The U.S. Food and Drug Administration has given the green light to the use of mepolizumab (produced under the name Nucala by GlaxoSmithKline) as treatment in severe cases of asthma for patients of 12 years or older with an eosinophilic phenotype.
FDA approves Mepolizumab for maintenance treatment of severe asthmaLedger Gazette
Nucala approved to treat severe asthmaExaminer.com
Nucala: FDA Approves GSK Drug for Severe AsthmaSMN Weekly (blog)

all 4 news articles »

View full post on asthma – Google News

Posted on

FDA approves Mepolizumab for maintenance treatment of severe asthma – Ledger Gazette


Ledger Gazette

FDA approves Mepolizumab for maintenance treatment of severe asthma
Ledger Gazette
The US Food and Drug Administration has cleared use of Nucala (mepolizumab) in patients with severe asthma aged 12 years and older whose condition is driven by eosinophilic inflammation, offering patients access to the first and only approved biologic …
Nucala approved to treat severe asthmaExaminer.com

all 2 news articles »

View full post on asthma – Google News